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Abstract  
Objective/Background: Insomnia is the most common sleep disorder in the general population.  
Pharmacological treatments have shown efficacy in the short term, yet the symptoms return once the treatment 
has been withdrawn.  In the search for treatment options with long-lasting effects, neurofeedback (NF) has arisen 
as a therapeutic option.  Neurofeedback is the application of operant conditioning to brain activity.  The aim of 
this work is to show the effectiveness of Live Z-Score NF training (LZT), a paradigm within the field of NF, in a 
case of insomnia.  Participants: A 32-year-old male with chronic insomnia since his adolescence.  Methods: 
Thirty 35-min sessions of qEEG-guided LZT using patient’s highly preferred feedback.  The main outcomes of 
this study were the patient’s qEEG metrics and a visual analog scale of sleep quality throughout the intervention.  
Results: qEEG-guided LZT showed an improvement of 90.63% of the patient’s qEEG metrics and an 82.55% 
relief of the clinical symptoms after 30 NF sessions.  Conclusions: Although more research is needed to 
establish that NF based on Live Z-Score is effective for insomnia, our results suggest that NF might be a 
therapeutic alternative for the treatment of insomnia. 
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Introduction  
 
About 20% to 30% of adults have some type of sleep 
disorders (Daley, Morin, LeBlanc, Grégoire, & 
Savard, 2009; Hammer, Colbert, Brown, & Ilioi, 
2011).  Insomnia is the most prevalent sleep disorder 
(Martínez Hernández, Lozano Olivares, & Álamo 
González, 2016), with around 21% of the population 
having at least one symptom of insomnia (Ohayon & 
Sagales, 2010) and between 6% and 10% of the 
general population presenting the full clinical 
syndrome of insomnia (Martínez Hernández et al., 
2016).  Pharmacological treatment for insomnia 
usually involves the use of benzodiazepines and 
antidepressants (NIH, 2005).  Pharmacological 
treatments for insomnia have shown efficacy during 
the first 6 months after the treatment is implemented, 
with a worsening of sleep quality after treatment 
withdrawal (Hammer et al., 2011).  This lack of long-
term effectiveness of pharmacological therapies has 
highlighted the need to search for pharmacological 
and nonpharmacological therapy combinations able 
to maintain clinical improvements.  Indeed, the 
combination of therapies seems to be more beneficial 
than monotherapy (Hammer et al., 2011). 
 
Regarding nonpharmacological therapies for 
insomnia, previous studies have analyzed 
neurofeedback (NF) interventions either as 
monotherapy or in combination with other therapies.  
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The findings reported in these studies suggest that 
NF could be beneficial to improve sleep quality 
(Hammer et al., 2011), to maintain long-term 
improvements, to reduce falling asleep latency 
(Hoedlmoser et al., 2008) and to reduce awakenings 
during sleep (Cortoos, De Valck, Arns, Breteler, & 
Cluydts, 2010). 
 
NF is a specialized field of biofeedback focused on 
the electroencephalographic (EEG) activity control 
(Carrobles, 2016), based on operant conditioning 
applications to EEG activity.  Operant conditioning is 
a learning procedure that relies on the use of 
reinforcement to increase the likelihood of a target 
response (Skinner, 1938).  Rewards are stimuli that 
are a thing of value to the organism and vary in 
degree across population.  In NF training, the 
targeted response consists of prespecified patterns of 
brain waves, and the patient is given the 
reinforcement every time his or her brain waves 
match the prespecified pattern (Chapin & Russell-
Chapin, 2014).   
 
The EEG activity is recorded by an amplifier and 
processed with specialized software that allows the 
breakdown of the EEG into frequency bands, and 
also to quantify the mean voltage or amplitude of each 
band in a specific moment (Carrobles, 2016; Demos, 
2005).  Through the application of NF, it is possible to 
reinforce, inhibit, or ignore the different bands.  For 
bands that are being reinforced, an amplitude 
threshold is established that must be exceeded to 
obtain feedback; for bands that are being inhibited, a 
threshold is established under which their amplitudes 
must remain in order to obtain reinforcement.  When 
more than one frequency band is being reinforced 
and/or inhibited, all set thresholds must be within the 
range set to receive feedback (Demos, 2005).  This 
feedback, which can be visual (e.g., films, 
animations), auditory (e.g., music) or mixed, is 
contingent on the fulfilment of the thresholds for each 
band in the EEG.  The clinician usually selects the 
amplitude thresholds for each frequency band in 
order to ensure that the patient receives feedback at 
least 50% of the time, although learning can take 
place even with feedback percentages between 20% 
and 70% (Soutar & Longo, 2011). 
 
Previous studies have shown that the application of 
NF has beneficial effects in patients with sleep 
problems (Arns, Feddema, & Kenemans, 2014; Arns 
& Kenemans, 2014; Halson, 2017; Hammer et al., 
2011; Schabus et al., 2014), while others have not 
shown superior effects compared to placebo 
(Schabus et al., 2017).  However, an important 
limitation related to the NF protocol is found across 
these studies.  The works by Arns et al. (2014), Arns 
and Kenemans (2014), Halson et al. (2017), and 
Schabus et al. (2017, 2014) assessed the effects of 
NF on the sensorimotor rhythm (SMR), a brain wave 
with a frequency in the range of 13 to 15 Hz that is 
recorded over the sensorimotor cortex (Arroyo et al., 
1993).  The SMR protocol was developed in the first 
place for the treatment of epilepsy and was later 
applied as a one-size-fits-all procedure for other 
conditions including attention-deficit/hyperactivity 
disorder (ADHD) or insomnia.  In the SMR protocol, 
brain waves are recorded in C3 or Cz sites, and 
reinforcement are provided when SMR amplitude is 
increased irrespective of other brain waves in other 
sites.  This means that the SMR protocol is not 
administered based on the individual’s qEEG profile 
(Cortoos et al., 2010; Hoedlmoser et al., 2008; 
Schabus et al., 2017, 2014), as waves at different 
brain sites are not trained.  
 
Hammer et al. (2011) compared a group receiving 
Z-score training guided by qEEG with a group 
receiving Z-score SMR training.  As participants 
receiving Z-score SMR training showed large 
movements toward Z-score normalization, these 
authors concluded that the Z-score training was 
probably more related to improvements in sleep 
quality than was the SMR element and the rewarding 
of SMR itself.  
 
The technological advances in recent years have 
allowed an increase in the possibilities of the NF 
(Hammer et al., 2011) through different paradigms: 
Z-score-based neurofeedback, infralow frequency 
neurofeedback, infraslow fluctuation neurofeedback, 
or low-resolution electromagnetic tomography 
analysis (LORETA)-based neurofeedback.  Some 
authors (Krigbaum & Wigton, 2015; Lubar, 2015; 
Wigton & Krigbaum, 2015) indicate that NF based on 
Live Z-Score (LZT) produces faster learning than 
conventional NF and has shown efficacy in different 
pathologies such as ADHD, epilepsy, migraine, 
depression, anxiety, and learning disorders (Guan, 
2016; Walker, 2016).  Hammer et al. (2011) used a 
4-channel LZT neurofeedback protocol based on the 
qEEG results and showed that it might be effective in 
improving both overall sleep quality and quantity in 
individuals with insomnia.  However, studies on the 
application of LZT in insomnia are scarce, both in 
group designs and in single-case designs.  The main 
objective of LZT is to train patient EEG Z-scores, 
deviated from the norm, to behave normally; it does 
so with a low probability that waves with a normal 
amplitude move out of the normal range (Pérez-Elvira 
et al., 2018).  To do this, all the patient's EEG 
Z-scores are computed and collected at all times, the 
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percentage of Z-scores within a specific range (±1 
standard deviation SD) is calculated, and the patient 
receives feedback every time the percentage of 
Z-scores within the normal range is equal to or higher 
than the requested percentage.  
 
The use of LZT is aimed at normalizing extreme 
Z-scores, while outliers are avoided so as to not 
overtrain them.  Thus, the brain has sufficient 
freedom to choose a path of self-regulation that is not 
limited to training towards the norm (Collura, Guan, 
Tarrant, Bailey, & Starr, 2010).  In other words, the 
brain accommodates itself to normalize with a certain 
degree of flexibility, since the main objective is to 
place a percentage of waves within the normal range.   
 
Amplitude NF allows for the training of a small number 
of targets at the same time and does not permit the 
safe increase of slow waves, such as delta (Soutar & 
Longo, 2011).  With LZT up to 248 simultaneous 
Z-scores (if four EEG channels are used) can be 
trained at the same time, and delta waves can be 
raised with a good safety margin since the limit is a 
normed Z-score, which is not the case with NF 
amplitude (Collura et al., 2010; Gracefire, 2016).  With 
LZT the clinician can read the patient's qEEG 
deviations in real time and adjust the reinforcement 
thresholds to optimize the intervention. 
 
There is a scarcity of LZT literature published in peer-
reviewed scientific journals (with institutional review 
board coverage) reporting targeted qEEG change 
(Krigbaum & Wigton, 2015; Wigton & Krigbaum, 
2015).  To our knowledge, only one previous study 
used LZT for insomnia (Hammer et al., 2011).  
Therefore, the aim of this study is to analyze the 
efficacy of LZT guided by qEEG in the treatment of 
chronic insomnia. 
 
Methods  
 
Patient  
The patient was a 32-year-old male, adopted when he 
was eight.  He suffered from chronic insomnia since 
his adolescence.  He had been receiving 
psychological treatment from an early age for night 
terrors and sensory deprivation suffered before his 
adoption.  He started his schooling at eight years of 
age, because up to that moment he had 
environmental and psychosocial problems.  
When this study began, he was working as a 
carpenter and was still receiving psychological 
treatment aimed at improving social skills for 
problems related to self-esteem.  His educational 
level was primary school. 
 
Main Complaints 
The patient consulted our clinic, looking for a 
nonpharmacological treatment, because of 
complaints related to quantity and quality of sleep. 
 
He had problems falling and staying asleep during the 
night and had frequent and vivid nightmares.  The 
patient was unable to fall asleep, once lying down, 
until after more than an hour, and woke up frequently 
during the night without managing to maintain sleep 
more than 4 hours.  Before starting treatment with NF, 
he received pharmacological treatment for insomnia 
(quetiapine 100 mg).  Yet he often woke up during the 
night and felt anxious.  This fact conditioned the rest 
of his day, both at work and in his social life.  In 
addition, the patient expressed a desire to withdraw 
the medication. 
 
The main objectives of the patient were to (1) fall 
asleep, to reduce the time between lying down and 
starting to sleep to less than 20 minutes; (2) stay 
asleep during most of the night, the total sleep time to 
be at least 6 hours; (3) feel refreshed after sleeping; 
and (4) withdraw sleep medication without worsening 
the quantity and quality of sleep. 
 
The patient provided written informed consent for the 
intervention and the publication of this study, which 
was undertaken at NEPSA Rehabilitación 
Neurológica, a neurologic rehabilitation clinic 
authorized by the Regional Department of Health 
(Castilla y León, Spain).  The Regional Department of 
Health provided approval for this kind of intervention.   
 
Instruments and Procedure  
qEEG Recording and Analysis.  A qEEG was 
obtained before starting the NF intervention, and after 
every 10 NF sessions.  To obtain the EEG, the patient 
was fitted with a 19-channel (Electro-cap 
International, Eaton, OH) according to the 
International 10–20 System with linked-ear montage 
(Fp1, Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, 
P3, Pz, P4, T6, O1, and O2).  For 3 min, the EEG 
signals were obtained and collected simultaneously 
over these 19 channels with a Discovery 20 amplifier 
(BrainMaster Technologies, Inc., Bedford, OH).  The 
EEG recordings were recorded in eyes-closed 
condition, using BrainAvatar 4.6.4 software 
(BrainMaster Technologies, Inc., Bedford, OH). 
 
The EEG signals were then imported into the 
NeuroGuide v2.9.1 software (Applied Neuroscience, 
Inc., Largo, FL) for computation and analysis, where 
artifacts (i.e., activity collected from the EEG that is 
not produced by the brain) were visually inspected 
and removed, retaining 1 min and 33 s with a test–
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retest value of 0.93.  The EEG was processed with 
linked-ear montage and compared with the 
NeuroGuide normative database, and Z-score values 
were obtained in order to identify the patient’s brain 
waves that were out of range. 
 
Visual Analog Scale.  Prior to starting the NF 
intervention, the patient rated his sleep quality using 
a subjective visual scale.  The visual scale included a 
10 cm line with numbers from 0 to 100, with 0 being 
no sleep problems and 100 being the worst sleep 
quality.  This scale was administered before the NF 
intervention and after every 10 sessions during the 
intervention.  The upscale was also administered 
after 1-, 3-, and 6-month follow-ups.  
 
Intervention 
Live Z-Score Training (LZT) Neurofeedback.  We 
used qEEG-guided LZT.  Since C3, C4, P3, and P4 
were the most deviated waves from normal range at 
pretreatment, they were selected for NF intervention.  
We used a 4-channel linked ears montage and the 
BrainAvatar 4.6.4 Z-Score PZOKUL protocol 
(BrainMaster Technologies, Inc., Bedford, OH). 
 
This protocol has a training threshold that auto-
adjusts based on the percentage of Z-scores within 
the upper and lower selected limits.  In this study, 1 
SD was used as the upper and lower thresholds 
(Thatcher & Lubar, 2014).  The patient received one 
35-min session twice a week for 15 weeks without 
interruption, with a total of 30 LZT sessions.  The 
patient was offered to choose both the form of 
feedback (e.g., auditory or visual) and the type of 
feedback (e.g., sounds, music, videogames, movies, 
etc.) within each session.  According to the patient’s 
preferences, different movies selected by the patient 
were used to produce the feedback.  This procedure 
is a modification of the procedure used in previous 
studies where the same form and type of feedback 
was selected by the researcher and used for all 
participants.  For instance, Schabus et al. (2017, 
2014) and Hoedlmoser et al. (2008) used the drawing 
of a sun along with a sound, whereas other studies 
did not specify what feedback was used (Cortoos et 
al., 2010; Hammer et al., 2011).  We allowed the 
patient to choose both the form and the type of 
feedback in each session because, as previous 
studies have shown (Fisher et al., 1992; Mangum, 
Fredrick, Pabico, & Roane, 2012; Piazza, Fisher, 
Hagopian, Bowman, & Toole, 1996),  rewards that are 
more relevant for the subject have a superior learning 
effect.  
 
A dimmer was placed in front of the video screen that 
offered sharpness when the patient met the criteria 
set by the LZT protocol or became opaque, 
preventing the video from being viewed, when the 
criteria were not met. 
 
Statistical Analysis 
To analyze the change in EEG values, Z-scores were 
obtained for each location and frequency band, with 
a total of eight bands (Table 1).  These Z-scores were 
dichotomized as within (i.e., ±1 SD) or outside the 
norm.  The number of Z-scores within the limits of 
normality every 10 sessions was calculated.  The 
McNemar test was used for related data to analyze 
whether significant changes occurred after each 
block of 10 sessions. 
 
To analyze the clinical change, we used the 
percentage change of the values of the visual sleep 
quality scale. 
 
Results  
 
The pretreatment qEEG showed that all brain waves 
were under the lower limit for all four locations in all 
frequency bands (Table 1), mainly in the delta and 
beta bands, and in central, parietal, and occipital 
regions (Figure 1).  The patient scored 86 on the 
visual analog sleep quality scale (Figure 2).  The 
percentage of Z-scores within the normal limits was 
0% (Tables 2 and 3). 
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Figure 1. Surface maps of Z-scores distribution (full EEG). 1 = Baseline 
qEEG, 2 = after 10 LZT sessions qEEG, 3 = after 20 LZT sessions qEEG,  
4 = after 30 LZT sessions qEEG. 
 
 
Table 1 
Z-scores per channel and frequency, and 
evaluation. 
Channels 
Delta 
Initial 
Delta 
10NF 
Delta 
20NF 
Delta 
30NF 
C3 −2.38 −1.37 −0.64 −0.69 
P3 −1.83 −1.60 −0.56 −0.83 
C4 −1.82 −0.92 −0.67 −0.57 
P4 −2.63 −0.96 −0.83 −0.47 
     
Channels 
Theta 
Initial 
Theta 
10NF 
Theta 
20NF 
Theta 
30NF 
C3 −1.66 −0.22 0.35 0.33 
P3 −1.46 −0.52 0.13 0.09 
C4 −1.30 0.21 0.10 −0.09 
P4 −1.77 0.12 0.57 0.71 
 
 
Channels 
Alpha 
Initial 
Alpha 
10NF 
Alpha 
20NF 
Alpha 
30NF 
C3 −1.64 −0.73 −0.24 −0.36 
P3 −1.46 −0.90 −0.59 −0.56 
C4 −1.47 −0.69 −0.41 −0.33 
P4 −1.65 −0.71 −0.58 −0.44 
 
Channels 
Beta 
Initial 
Beta 
10NF 
Beta 
20NF 
Beta 
30NF 
C3 −1.80 −1.19 −0.57 −0.47 
P3 −1.91 −1.43 −0.98 −0.72 
C4 −1.65 −1.08 −0.78 −0.91 
P4 −2.19 −1.22 −1.08 −0.94 
Note. Initial = 1st qEEG, 10NF = after 10 NF sessions, 
20NF = after 20 NF sessions, 30NF = after 30 NF sessions.  
Z-scores out of range are marked in blue ink. 
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Table 1 (continued). 
Channels 
Hi Beta 
Initial 
Hi Beta 
10NF 
Hi Beta 
20NF 
Hi Beta 
30NF 
C3 −1.32 −1.11 −1.15 −1.01 
P3 −1.45 −1.33 −1.01 −0.89 
C4 −1.42 −1.32 −1.16 −0.97 
P4 −1.38 −1.25 −1.01 −0.66 
     
Channels 
Beta1 
Initial 
Beta1 
10NF 
Beta1 
20NF 
Beta1 
30NF 
C3 −1.31 −0.72 −0.19 −0.34 
P3 −1.58 −1.15 −0.84 −0.72 
C4 −1.21 −0.45 −0.34 −0.84 
P4 −1.78 −0.99 −0.98 −0.88 
     
Channels 
Beta2 
Initial 
Beta2 
10NF 
Beta2 
20NF 
Beta2 
30NF 
C3 −1.39 −0.97 0.13 0.29 
P3 −1.61 −1.19 −0.47 −0.23 
C4 −1.19 −0.79 −0.19 −0.13 
P4 −1.69 −0.69 −0.54 −0.59 
     
Channels 
Beta3 
Initial 
Beta3 
10NF 
Beta3 
20NF 
Beta3 
30NF 
C3 −1.91 −1.53 −1.36 −0.96 
P3 −1.87 −1.58 −1.28 −0.87 
C4 −1.87 −1.76 −1.50 −1.30 
P4 −2.18 −1.62 −1.34 −1.05 
Note. Initial = 1st qEEG, 10NF = after 10 NF sessions, 
20NF = after 20 NF sessions, 30NF = after 30 NF sessions.  
Z-scores out of range are marked in blue ink. 
 
 
After the first 10 sessions of LZT, 16 of the 32 
Z-scores (50%) were within the normal range (Tables 
2 and 3), which is a statistically significant change 
relative to baseline assessment (χ² = 14.06, p < .001).  
Also, the qEEG maps showed an overall 
improvement (Figure 1), despite maintaining low 
voltage in all frequency bands.  After these 10 LZT 
sessions, the patient identified a 22.09% 
improvement in sleep quality (Figure 2). 
 
Figure 2. Sleep Quality Visual Analog Scale. 
Pretreatment, after 10NF, 20NF, and 30NF sessions, and 
1-month (M), 3 M, and 6 M follow-up. 100 = worst sleep 
quality, 0 = best sleep quality. 
 
 
After 20 LZT sessions, the maps again showed an 
overall improvement (Figure 1), with higher voltage in 
all bands and 71.88% of Z-scores within the norm 
(Tables 2 and 3), a significant change compared to 
the previous measurement (χ² = 5.14, p = .011).  The 
patient identified an improvement of 48.83% 
compared to the previous assessment on the 
analogue visual scale (Figure 2) measuring sleep 
quality. 
 
 
Table 2 
Percentage of Z-scores within the normal limits for 
every measurement distributed by frequency. 
 
Number of Z-scores 
within the limits 
% within the limits 
Initial 0 0.00% 
10NF 16 50.00% 
20NF 23 71.88% 
30NF 29 90.63% 
Note. Initial = First qEEG, 10NF = after 10 sessions qEEG, 
20NF = after 20 sessions qEEG, 30NF = after 30 sessions 
qEEG. 
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Table 3 
Percentage of Z-scores within the normal limits for 
every measurement distributed by channel. 
Number of 
Z-scores 
within the 
limits 
C3 P3 C4 P4 
Initial 0 0 0 0 
10NF 4 2 5 5 
20NF 6 6 6 5 
30NF 7 8 7 7 
     
% within 
the limits 
C3 P3 C4 P4 
Initial 0% 0% 0% 0% 
10NF 50.0% 25.0% 62.5% 62.5% 
20NF 75.0% 75.0% 75.0% 62.5% 
30NF 87.5% 100.0% 87.5% 87.5% 
Note. Initial = First qEEG, 10NF = after 10 sessions qEEG, 
20NF = after 20 sessions qEEG, 30NF = after 30 sessions 
qEEG. 
 
 
After 30 LZT sessions, additional improvements were 
found in the qEEG maps (Figure 1), with higher 
voltage in all bands and an improvement of 82.5% in 
sleep quality compared to the initial measurement 
(Figure 2).  It can be observed that 90.63% of 
Z-scores were in the normal range after the last LZT 
session (Tables 2 and 3), which is a statistically 
significant improvement compared to baseline 
assessment (χ² = 4.17, p = .02).  
 
Regarding the channel scores, P3 showed 100% of 
the Z-scores within the normal range after 30 
sessions of NF, whereas C3, C4, and P4 showed 
87% of Z-scores within the normal range.  As can be 
seen in Table 1, none of the waves within the normal 
range deviated from normality (i.e., ±1 SD).  
 
Data on subjective perception of sleep quality after 1-, 
3-, and 6-month follow-ups showed no difference 
compared to the last measurement of the intervention 
phase, indicating a maintenance of the improvements 
achieved after 30 sessions of LZT. 
 
Discussion  
 
This study aimed to analyze the efficacy of LZT 
neurofeedback intervention for the treatment of 
chronic insomnia.  A qEEG-guided LZT protocol was 
designed for this purpose.  The results showed that 
LZT was effective in modifying EEG patterns and 
bringing EEG metrics within the normal range after 
thirty 35-min sessions of NF.  In addition, the patient 
was able to discontinue the use of sleep medication 
after 20 sessions.  
 
These results are consistent with previous works.  
Hammer et al. (2011) found improvements in sleep 
after 10 LZT sessions in people with insomnia. 
Krigbaum and Wigton (2015) analyzed 10 individuals 
with different conditions (attention-
deficit/hyperactivity disorder, anxiety disorder, and 
Asperger’s disorder) using 19-Channel Z-score NF 
during 6 to 15 NF sessions.  They identified the sites 
of interest as any electrode sites which had Z-scores 
of either Z ≥ 1 or Z ≤ −1, and then analyzed those that 
moved towards values of Z = 0.  Their findings 
showed that 45 sites of interest out of 50 (90%) 
moved in the targeted direction, a finding similar to 
the results reported in the present study using a 
similar methodology, even though we used the 
criterion of Z-scores falling within the normal range 
(Z-scores between ±1) rather than moving toward z = 
0.  
 
Our data indicate that after 10 sessions of LZT there 
was a trend towards normalization of Z-scores, and 
after 30 sessions the total computation of Z-scores 
was very close to normal.  Likewise, the patient 
interrupted the pharmacological treatment and 
identified an improvement of 83% in the subjective 
perception of the quality of sleep.  Sleep quality was 
measured with a visual analog scale during the 
intervention and in the follow-up, with maintenance of 
sleep quality at the end of the intervention and 
withdrawal of the medication.  Our results showed a 
difference of 71 points between baseline and the last 
NF session.  This difference, which is higher than the 
difference considered clinically relevant by Zisapel 
and Nir (2003) using a 100 points visual analog scale 
for measuring quality of sleep, highlights the clinical 
importance of the LZT and supports the clinical 
relevance reported in previous works (Hammer et al., 
2011; Krigbaum & Wigton, 2015; Wigton & Krigbaum, 
2015). 
 
One of the strengths of this work is that the effects of 
NF were assessed both immediately after treatment 
and after 1-, 3-, and 6-months follow-ups.  This is an 
improvement over other studies which, as far as we 
know, either did not follow up (Hoedlmoser et al., 
2008; Schabus et al., 2017, 2014) or only did it at one 
time.  For instance, Hammer et al. (2011) had a 6- to 
9-month follow-up, and Cortoos et al. (2010) had a 
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2-week follow-up after the treatment was completed.  
Interestingly, our results after 6 months of follow-up 
are similar to those reported by Hammer et al. (2011), 
who found a good sleep quality in their participants 
after 6 months of follow-up.  Additionally, it must be 
noted that the improvement in sleep quality in the 
patient described here continued even after the 
patient withdrew the medication. 
 
In the present study, qEEG was used to guide 
treatment with LZT, which allowed specification of the 
brain waves that would be the sites of interest for the 
intervention.  This could explain the differences with 
the study by Schabus et al. (2017), who concluded 
that treatment with NF was not superior to placebo for 
insomnia.  It should be noted that in their study they 
used the SMR protocol, which was not qEEG-guided 
and was applied similarly to every participant.  
Regarding feedback, stimulus used to work as 
reinforcer for some subjects might not work for others 
(Mangum et al., 2012).  The NF is based on the 
application of the operant conditioning for the 
modulation of the EEG activity, so it is important that 
the feedback is a real reinforcer relevant for the 
individual patient (Fisher et al., 1992).  The feedback 
used by Schabus et al. (2017) appears to have little 
probability of being a true reinforcer for the subjects 
in their study because they were not selected by the 
subjects and might not work as a reinforcer.  It should 
be added that the results of Schabus et al. (2017) 
contradict other studies that showed that the use of 
different NF protocols improved sleep latencies in 
children and adults with ADHD (Arns et al., 2014; 
Arns & Kenemans, 2014).  Both the protocol and the 
feedback used by Schabus et al. (2017) could 
partially explain their negative results.  In contrast, our 
study used patient’s highly preferred feedback, so it 
is are assumed to have a higher reinforcing value 
(Fisher et al., 1992; Piazza et al., 1996). 
 
The results of this case suggest the need to 
investigate the efficacy of LZT not only as a treatment 
for insomnia but also as a tool to normalize brain 
activity, including low-voltage cases.  Despite our 
results, this study had numerous limitations, including 
sample size, which was reduced to a single case 
without a control group.  In the protocol used in the 
present study, following the fundamental principles of 
operant conditioning, and in order to ensure that 
feedback had real reinforcing value, the patient was 
allowed to choose the feedback to be used.  Although 
this could guarantee the reinforcing value of the 
material, this procedure makes our results not 
comparable with previous works that did not allow the 
patient to select a relevant reinforcer.  Also, sleep 
quality was measured with a visual analog scale, as 
used in previous research on insomnia (Zisapel & Nir, 
2003), but it probably only reflects very generally the 
quality of sleep.  It is therefore necessary to include 
objective measures of sleep quality to correlate 
subjective improvements with objective physiological 
measures.  Similarly, the effect of reinforcer selection 
on the neurometric results of the intervention with LZT 
and other types of NF should be analyzed.  As for the 
measures of sleep quality, insomnia is a multicausal 
pathology and with several dimensions to take into 
account (e.g., hours of sleep, latency time until 
conciliation of the same, awakenings during the 
night).  Thus, scales and other instruments are 
needed that could sufficiently cover the different 
dimensions of sleep. 
 
In conclusion, LZT seems to be a good approach to 
NF not only because of its rapid resolution of 
symptoms and normalization of brain activity but also 
because of its safety margin for increasing slow 
waves.  In the case of insomnia, LZT may be a better 
option than pharmacological treatment.  As shown by 
this 30-session intervention, NF may achieve long-
lasting effects, may normalize the EEG, and may also 
improve subjective quality of sleep in chronic 
insomnia, without producing adverse reactions or 
side effects. 
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